SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada
Milestone Coincides with SK Biopharmaceuticals’ Global Plan Expanding Cenobamate Access to More Than…
China-Malaysia Diplomatic Relations Commemorate 50th Anniversary with Successful Conclusion of the 2nd China-Malaysia Science and Technology Innovation Summit
KUALA LUMPUR, Malaysia, March 12, 2024 /PRNewswire/ — The 2nd China-Malaysia Science…